Loss of extracellular superoxide dismutase induces severe IL-23-mediated skin inflammation in mice

Yun Sang Lee, In Su Cheon, Byung Hak Kim, Myung Ja Kwon, Han Woong Lee, Tae Yoon Kim

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Psoriasis is a common chronic and complex autoimmune inflammatory skin disorder. The histological characteristics of psoriasis are epidermal hyperplasia, mononuclear leukocyte infiltration into the dermis, and increased angiogenesis. However, the mechanisms involved in the pathogenesis of psoriasis remain unclear. Extracellular superoxide dismutase (EC-SOD) has antichemotactic activities. Because immune cell infiltration is seen in psoriatic lesions and psoriasis patients express low levels of EC-SOD, we hypothesized that the lack of EC-SOD induces more severe IL-23-mediated psoriasis-like skin inflammation. To test this hypothesis, we determined whether the loss of EC-SOD causes more severe IL-23-induced skin inflammation. Ear skin after IL-23 administration was thicker in EC-SOD knockout (KO) mice compared with wild-type mice. In addition, infiltration of CD4+ T cells, macrophages, and dendritic cells (DCs) into IL-23 injection sites was more elevated in EC-SOD KO mice. The expression of proinflammatory cytokines and chemokines was also more elevated in EC-SOD KO mice, and EC-SOD KO DCs expressed a higher level of MHCII. Finally, EC-SOD transgenic mice showed much less severe IL-23-induced skin inflammation. Therefore, EC-SOD may inhibit IL-23-induced psoriasis-like inflammation through the inhibition of immune cell infiltration and immune responses. These results suggest that EC-SOD could be a possible candidate for management of psoriasis.

Original languageEnglish
Pages (from-to)732-741
Number of pages10
JournalJournal of Investigative Dermatology
Volume133
Issue number3
DOIs
Publication statusPublished - 2013 Mar 1

Fingerprint

Interleukin-23
Superoxide Dismutase
Skin
Inflammation
Psoriasis
Infiltration
Knockout Mice
Dendritic Cells
Mononuclear Leukocytes
T-cells
Macrophages
Dermis
Chemokines
Transgenic Mice
Hyperplasia
Ear

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Dermatology
  • Cell Biology

Cite this

Lee, Yun Sang ; Cheon, In Su ; Kim, Byung Hak ; Kwon, Myung Ja ; Lee, Han Woong ; Kim, Tae Yoon. / Loss of extracellular superoxide dismutase induces severe IL-23-mediated skin inflammation in mice. In: Journal of Investigative Dermatology. 2013 ; Vol. 133, No. 3. pp. 732-741.
@article{20f35e1dbf6d4786a7685d0080838ff7,
title = "Loss of extracellular superoxide dismutase induces severe IL-23-mediated skin inflammation in mice",
abstract = "Psoriasis is a common chronic and complex autoimmune inflammatory skin disorder. The histological characteristics of psoriasis are epidermal hyperplasia, mononuclear leukocyte infiltration into the dermis, and increased angiogenesis. However, the mechanisms involved in the pathogenesis of psoriasis remain unclear. Extracellular superoxide dismutase (EC-SOD) has antichemotactic activities. Because immune cell infiltration is seen in psoriatic lesions and psoriasis patients express low levels of EC-SOD, we hypothesized that the lack of EC-SOD induces more severe IL-23-mediated psoriasis-like skin inflammation. To test this hypothesis, we determined whether the loss of EC-SOD causes more severe IL-23-induced skin inflammation. Ear skin after IL-23 administration was thicker in EC-SOD knockout (KO) mice compared with wild-type mice. In addition, infiltration of CD4+ T cells, macrophages, and dendritic cells (DCs) into IL-23 injection sites was more elevated in EC-SOD KO mice. The expression of proinflammatory cytokines and chemokines was also more elevated in EC-SOD KO mice, and EC-SOD KO DCs expressed a higher level of MHCII. Finally, EC-SOD transgenic mice showed much less severe IL-23-induced skin inflammation. Therefore, EC-SOD may inhibit IL-23-induced psoriasis-like inflammation through the inhibition of immune cell infiltration and immune responses. These results suggest that EC-SOD could be a possible candidate for management of psoriasis.",
author = "Lee, {Yun Sang} and Cheon, {In Su} and Kim, {Byung Hak} and Kwon, {Myung Ja} and Lee, {Han Woong} and Kim, {Tae Yoon}",
year = "2013",
month = "3",
day = "1",
doi = "10.1038/jid.2012.406",
language = "English",
volume = "133",
pages = "732--741",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "3",

}

Loss of extracellular superoxide dismutase induces severe IL-23-mediated skin inflammation in mice. / Lee, Yun Sang; Cheon, In Su; Kim, Byung Hak; Kwon, Myung Ja; Lee, Han Woong; Kim, Tae Yoon.

In: Journal of Investigative Dermatology, Vol. 133, No. 3, 01.03.2013, p. 732-741.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Loss of extracellular superoxide dismutase induces severe IL-23-mediated skin inflammation in mice

AU - Lee, Yun Sang

AU - Cheon, In Su

AU - Kim, Byung Hak

AU - Kwon, Myung Ja

AU - Lee, Han Woong

AU - Kim, Tae Yoon

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Psoriasis is a common chronic and complex autoimmune inflammatory skin disorder. The histological characteristics of psoriasis are epidermal hyperplasia, mononuclear leukocyte infiltration into the dermis, and increased angiogenesis. However, the mechanisms involved in the pathogenesis of psoriasis remain unclear. Extracellular superoxide dismutase (EC-SOD) has antichemotactic activities. Because immune cell infiltration is seen in psoriatic lesions and psoriasis patients express low levels of EC-SOD, we hypothesized that the lack of EC-SOD induces more severe IL-23-mediated psoriasis-like skin inflammation. To test this hypothesis, we determined whether the loss of EC-SOD causes more severe IL-23-induced skin inflammation. Ear skin after IL-23 administration was thicker in EC-SOD knockout (KO) mice compared with wild-type mice. In addition, infiltration of CD4+ T cells, macrophages, and dendritic cells (DCs) into IL-23 injection sites was more elevated in EC-SOD KO mice. The expression of proinflammatory cytokines and chemokines was also more elevated in EC-SOD KO mice, and EC-SOD KO DCs expressed a higher level of MHCII. Finally, EC-SOD transgenic mice showed much less severe IL-23-induced skin inflammation. Therefore, EC-SOD may inhibit IL-23-induced psoriasis-like inflammation through the inhibition of immune cell infiltration and immune responses. These results suggest that EC-SOD could be a possible candidate for management of psoriasis.

AB - Psoriasis is a common chronic and complex autoimmune inflammatory skin disorder. The histological characteristics of psoriasis are epidermal hyperplasia, mononuclear leukocyte infiltration into the dermis, and increased angiogenesis. However, the mechanisms involved in the pathogenesis of psoriasis remain unclear. Extracellular superoxide dismutase (EC-SOD) has antichemotactic activities. Because immune cell infiltration is seen in psoriatic lesions and psoriasis patients express low levels of EC-SOD, we hypothesized that the lack of EC-SOD induces more severe IL-23-mediated psoriasis-like skin inflammation. To test this hypothesis, we determined whether the loss of EC-SOD causes more severe IL-23-induced skin inflammation. Ear skin after IL-23 administration was thicker in EC-SOD knockout (KO) mice compared with wild-type mice. In addition, infiltration of CD4+ T cells, macrophages, and dendritic cells (DCs) into IL-23 injection sites was more elevated in EC-SOD KO mice. The expression of proinflammatory cytokines and chemokines was also more elevated in EC-SOD KO mice, and EC-SOD KO DCs expressed a higher level of MHCII. Finally, EC-SOD transgenic mice showed much less severe IL-23-induced skin inflammation. Therefore, EC-SOD may inhibit IL-23-induced psoriasis-like inflammation through the inhibition of immune cell infiltration and immune responses. These results suggest that EC-SOD could be a possible candidate for management of psoriasis.

UR - http://www.scopus.com/inward/record.url?scp=84873736060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873736060&partnerID=8YFLogxK

U2 - 10.1038/jid.2012.406

DO - 10.1038/jid.2012.406

M3 - Article

C2 - 23223134

AN - SCOPUS:84873736060

VL - 133

SP - 732

EP - 741

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 3

ER -